Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
filingDate |
2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42cdd7280d34bc46f0f48c750c4cd0d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9803ff6b5a66235d070279beccd7a8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7c4f3ea7acbd1be32d464e49da0e52c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990cc26e75de2c7156ad194c2f3f8268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0783254583b301be23e824b528a2e08a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b35ce4502f661fcc5f3d3e7f9befe8e |
publicationDate |
2022-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022229846-A1 |
titleOfInvention |
Treatment of cancer using a transforming growth factor beta receptor type 1 inhibitor |
abstract |
This invention relates to methods for the treatment and selection of subjects having cancer who may benefit from administration of a TGFβr1 inhibitor. |
priorityDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |